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In  1954 Pillemer and associates  (2)  introduced the properdin system as  a 
humoral mechanism of natural resistance to infections. Although this provoca- 
tive hypothesis generated a large body of literature, it could not be critically 
evaluated until recently. The past 5 yr of complement research brought to light 
an unanticipated complexity of the properdin system. The design of a rational 
model of the properdin pathway had to await identification of the major compo- 
nents and insight into their interactions. 
In this communication and subsequent papers (3 and footnote 1), we wish to 
report the results of experiments that together with previously published obser- 
vations have allowed the formulation of a comprehensive molecular concept of 
the properdin pathway (4). The dynamics of the pathway involve the recruit- 
ment of the initiating factor (IF), 2 sequential formation of C3 and C5 conver- 
tases,  activation of properdin, and stabilization of the enzymes by activated 
properdin.  The biological consequences of this process are identical to those 
resulting from activation of the classical pathway: generation of the anaphyla- 
toxins,  immune adherence reactivity, opsonic  activity, and formation of the 
membrane attack complex. 
The purpose of this paper is to describe (a) the initiating factor as a  novel 
serum protein, (b) its function in the assembly of the initial C3 convertase of the 
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pathway, and (c) the ability of the entire pathway to function in the absence of 
properdin. 
Materials and Methods 
Purified Components.  Highly purified C3 (5), Factor B  (6), Factor D  (7), activated properdin 
(8),  C4  (9),  C5  (5),  and  cobra  venom  factor  (CVF)  (10)  were  isolated  by  previously  reported 
methods. 
Buffers.  VB:  isotonic Veronal-buffered saline,  pH  7.4.  VB+÷:  VB containing 1.5  x  10 -4  M 
CaC12 and 5  x  10 -4 M  MgC12. Mg-GVB: VB containing 0.1% gelatin and 1.3  x  10 -3 M  MgSO4. 
GVBE: VB containing 0.1% gelatin and 0.04 M EDTA. 
Preparation of Immune Adsorbents.  The IgG fractions of various antisera were  covalently 
coupled to CNBr-Sepharose (Pharmacia Fine Chemicals, Piscataway, N. J.) utilizing the method 
of March et al.  (11).  The antisera to properdin and Factor D were raised in rabbits, the antisera 
to Factor B,  C4,  and nephritic factor (NF)  were raised in goats.  NF was purified as described 
(12), subjected to polyacrylamide gel electrophoresis, and the NF activity containing eluates from 
gel segments were used for immunization. 
Immune Adsorption  of Normal Human Serum.  Fresh normal human serum  was  immuno- 
chemically depleted of various components by the method described previously (12).  Recovery of 
material specifically bound to the immune adsorbent was accomplished by elution with 0.2  M 
glycine HC1 buffer, pH 2.2, and collection of fractions into an equal volume of 0.2 M Na2HPO4. The 
eluate was dialyzed against phosphate-buffer saline and concentrated. 
Zymosan orInulin Tests.  The ability ofzymosan or inulin to activate the alternative pathway 
in the various depleted sera was assessed by addition of 250 ~g of activator to 50 ~l of serum in a 
final vol of 70 ~1 and a final concentration of magnesium ions ofl.2 x  10  -3 M. After incubation for 
30 or 60 min at 37°C,  the reaction was stopped by addition of GVBE and lowering the temperature 
to 0°C.  C3 consumption was determined by effective molecule titrations as described elsewhere 
(13). 
Immunofluorescence.  The  detection  of surface  bound  C3  and  properdin  was  accomplished 
using the direct immunofluorescence technique employing (FITC) fluorescein isothiocynate-conju- 
gated antibody prepared according to the method of Clark and Shepard (14). The antiserum to C3 
was obtained by immunizing rabbits with the isolated protein. The antiserum was specific for the c 
and the d portion of C3b. 
Electrophoresis,  Disk electrophoresis was  performed using the method of Davis  (15)  in 6% 
running gels and Tris-HCl-glycine buffer, pH 8.9.  Sodium dedecyl sulfate (SDS) polyacrylamide 
gel electrophoresis was performed according to the method of Weber and Osborn (16) as reported 
previously (9). Analytical agarose block electrophoresis was carried out on 5 ×  7.6-cm glass slides 
containing 10 ml of 1.2% agarose dissolved in 0.044 M barbital-HC1 buffer, pH 8.6, containing 0.01 
M EDTA for 2 h  at 5.3 V/cm. 
Sucrose Density  Gradient  Ultracentrifugation.  This  was  performed  in  5-ml  linear  7-31% 
sucrose density gradients in VB  ÷÷ at 40,000 rpm for 16 h at 4°C in a Beckman L5-65 ultracentrifuge 
(Beckman Instruments, Inc., Fullerton, Calif.).  Markers employed were IgG (6.6S), HSA (4.5S), 
and cytochrome c  (1.7S). 
Partial Purification  of IF.  The  serum  of 2  U  of freshly  drawn  normal  human  blood  was 
dialyzed against 3 x  10 liters of 0.005 M phosphate buffer, pH 7.3. The precipitate that formed was 
removed by centrifugation, and the pseudoglobulin fraction was applied to a 6 x 80-cm column of 
DEAE  cellulose  equilibrated  with  the  same  buffer.  The column  was  washed  with  3  liters of 
starting buffer, and IF was eluted with a 6-liter linear NaC1 concentration gradient, utilizing as 
limit buffer 0.005 M phosphate buffer, pH 7.3, containing 0.4 M NaC1. IF-containing fractions were 
pooled, concentrated to 15 ml, and subjected to molecular sieve chromatography on a  5  x  100-cm 
column of Bio-Gel A-0.5 M equilibrated with 0.01 M phosphate buffer, pH 7.3, containing 0.14 M 
NaC1.  After concentration,  the  IF-containing pool  was  passed  through an  immune adsorbent 
column containing antibody to IF and C3b inactivator (C3bINA). After washing, IF and C3bINA 
were eluted with 0.2 M glycine-HC1 buffer, pH 2.2. The eluted material was neutralized, dialyzed, 
and concentrated. IF and C3bINA could be separated by electrophoresis on 6% polyacrylamide gels 
at pH 8.9.  The gels were cut into 2-ram segments which were eluted with 200/~l of Veronal-buff- 
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to C3 consumption by zymosan. C3 consumption was quantitated as indicated above. C3bINA was 
measured by its ability to inactivate the classical C5 convertase on EAC4,°xY2,3. 1.5  x  107 assay 
cells were incubated for 10 min at 37°C with 20 ~1 of  eluted material in a total vol of 30 ~tl. The cells 
were then washed and incubated with 1 ml of C5-9  reagent to determine the reduction in C5 
convertase activity. 
Lysis of Rabbit Erythrocytes.  Rabbit erythrocytes were collected from freshly drawn EDTA 
blood, washed four times with GVBE, then three times with Mg-GVB. Cells were standardized to 
a final concentration of 1.5  x  10S/ml. Reaction mixtures for alternative pathway-mediated lysis of 
rabbit erythrocytes contained 100 ~1 Mg-GVB, 100  ~1 rabbit erythrocytes (at 1.5  x  l0  s erythro- 
cytes/ml), and 100  ~1 of serum usually diluted 1:5 in Mg-GVB. To ensure no contribution of the 
classical pathway, all sera were immunochemically depleted of C4. Additionally, in some experi- 
ments, the sera were adsorbed three times at  I°C with rabbit erythrocytes in the presence of 
EDTA. After incubation of the reaction mixtures at 37°C for 30 rain, the reaction was stopped by 
addition of 1 ml of cold GVBE. The remaining cells were pelleted and hemolysis determined by 
optical density measurements at 412 nm. 
Results 
The Initial C3 Convertase: A Properdin-Independent  Enzyme.  To examine 
the  possible  role  of properdin  in  the  initiation of the  pathway,  serum  was 
immunochemically depleted  of properdin.  To  eliminate  interference by  the 
classical pathway this and all other serum reagents were immunochemically 
depleted also of C4. Particulate inulin or zymosan were employed as characteris- 
tic activators of the properdin system. In absence of properdin, significant C3 
consumption and deposition of C3 on the activator particles was observed.  C3 
activation was dependent on the presence of Factors B and D and magnesium 
ions (Mg), as evidenced by abrogation of C3 utilization by further depletion of 
the serum reagent of either Factors B, D, or Mg (Table I). It is concluded from 
these results that serum allows the generation of an alternative C3 convertase 
in absence of properdin.  The function of this enzyme is to deposit C3b on the 
surface of the activating particle, where it serves as the receptor for activated 
properdin, as was shown previously (12). That bound C3b constitutes the only 
properdin receptor is indicated by negative properdin deposition on zymosan 
upon incubation with C3-deficient serum. 
Recognition of the IF.  In contrast to the above results, no C3 consumption or 
deposition were observed when zymosan was incubated with serum previously 
treated  with  solidified antibody to  NF  (Table  I).  The  negative  result  was 
obtained in spite of the fact that the anti-NF-treated serum contained undimin- 
ished  concentrations of properdin,  C3,  Factors  B  and  D,  and  sustained  C3 
consumption on addition of NF, activated properdin (P),  or CVF (Table II). 
Proteins specificially retained by the anti-NF immune adsorbent were eluted 
with acid buffer, dialyzed, and tested for the ability to reconstitute the anti-NF- 
treated serum. As shown in Table I, addition of a portion of the eluate to the 
treated serum restored C3 consumption and C3 and properdin deposition in the 
presence of zymosan. In this Table the activity is referred to as IF to distinguish 
it from NF activity which has not been found in normal serum. When properdin 
was removed from IF-depleted serum and the serum was restored with respect to 
IF activity, significant C3 binding to zymosan was observed which, however, 
was lower than in properdin-containing serum. 
That  IF  was  recovered  from  the  immune  adsorbent  in  precursor  form  is 
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TABLE  I 
Initiation in Absence of Properdin(P): Requirement of Initiating Factor, Factors B, D, 
and Native C3 for Formation of the Properdin Receptor-Forming Enzyme 
C4-deficient  Material  serum de-  added  pleted of 
C3 consumption* 
+ Zymosan  + NaCI 
Deposition on zymosan 
,25I.C3:~ 
Immunofluorescence* 
C3  P 
%  cpm 
P  22.4  6.9  ND  2+  0 
P, B  2.8  1.8  ND  0  O 
P, D  0.6  4.1  ND  0  0 
C3  ND  ND  ND  0  0 
Me  ++ (EDTA)  0  0  ND  0  0 
IF  1.8  4.5  237  0  0 
IF  IF  54.6  7.8  6,423  4+  4+ 
P, IF  10.1  10.O  210  0  0 
P, IF  IF  ND  ND  2,871  ND  ND 
Nothing  50.0  10.0  ND  4 +  4 + 
Nothing  C4  78.6  14.7  ND  4 +  4 + 
* Reaction mixtures  containing 50/~I  serum, 250 ~g  zymosan, 10  -s  M  Mg  ++  incubated 30  or  60  rain 
at 37°C.  C3 consumption determined by effective  molecule titration.  Zymosan particles  were 
washed and incubated 45  min with  the  FITC-conjugated  IgG  fraction  of  monospecific  antisera  to 
C3 or P. 
* Reaction mixtures as above plus 490 ng 12sI-C3 added  to serum reagents. After incubation, 
zymosan was washed three times, transferred to fresh tubes, and analyzed for radioactivity. 
TASLE II 




pleted  of 
Concentration*  C3 Consumption upon addition of 
P$  C3§  B$  I~l  Zymosan  P  NF  CVF 
%  %  %  % 
IF  >90  100  105  100  O  99.8  10O  96.7 
Nothing  >90  100  100  100  56  98.4  99.6  94.6 
* Percent of  concentration in  the untreated serum. 
* Determined by radial  immunodiffusion. 
§ Determined by effective  molecule titration. 
II Determined by the hemolytic method utilizing  CVF and glutathione-treated  human erythro- 
cytes  (17). 
on  addition  of  IF  alone,  however,  it  approached  completion  in  presence  of 
zymosan. 
The experiments described  so  far indicate that  the  initial C3  convertase is 
generated from IF and Factors B  and D  in the presence of Mg.  Because of its 
function, IF was given the trivial name  initiating factor. 
To clearly establish the  sequence of action of IF and properdin,  a  transfer 1066  ALTERNATIVE  PATHWAY  OF  COMPLEMENT 
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FIG.  1.  Reconstitution of IF-depleted serum by IF-purified immunochemically in precur- 
sor form. This is demonstrated by zymosan-dependent consumption of C3 as a function of IF. 
50 ttl IF-depleted serum was incubated with varying amounts of  IF in presence or absence of 
zymosan for 30 rain at 37°C. C3 consumption determined by effective molecule titration. 
TABLE  III 
Generation of Properdin(P)-Stabilized  C3 Convertase by Sequential Treatment of 
Zymosan  with P-Depleted and IF-Depleted Serum 
First treat- 
ment* with 
Result of first treatment  Result of second treatments with 
IF-depleted HS 
Con-  Deposition  Consump-  Deposition  p  sump-  P 
tion C3  C3  C3  tion C3 
P-depleted HS  22.4  2+  0  49  4+  4+ 
C3-deficient HS  0  0  0  0  0  0 
NaC1  0  0  0  0  0  0 
* Zymosan treated for 60 min at 37°C with reagent, washed with GVBE, kept for 2 h at 22°C and for 
16 h at 4°C. 
Treated for 30 min at 37°C with reagent. 
experiment was performed. Zymosan was first incubated in properdin-depleted 
serum, washed extensively, and then incubated in IF-depleted serum. Table III 
shows  that  during  the  first  incubation  C3  was  deposited  on the  particles  in 
absence of properdin. During the second incubation, properdin was deposited in 
absence of IF and C3 consumption and uptake increased.  This experiment not 
only establishes  the  sequence of action,  but  together with  the  above results, 
shows that C3 deposition,  as affected by the IF-dependent C3 convertase, is  a 
prerequisite  for properdin binding.  This  enzyme therefore  may be  called  the 
properdin receptor-forming enzyme. 
Partial Purification and Characterization of the IF.  Fig.  2 shows that the 
unactivated form of  IF in serum migrates as a  fl-globulin upon electrophoresis at 
pH 8.6 in 1% agarose gel.  Fig. 3 demonstrates the behavior of IF on molecular 
sieve chromatography using Sephadex G-150.  Its apparent filtration rate indi- 
cates a  mol wt of 70,000-120,000 daltons. 
Partial purification was achieved by a four-step procedure. Since IF was found 
to be a pseudoglobulin, the pseudoglobulin fraction of normal human serum (400 
ml) was prepared and subjected to anion exchange chromatography using DEAE R.  D.  SCHREIBER,  O.  GOTZE,  AND  H.  J.  MT.~LLER-EBERHARD  1067 
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FIG.  2.  Electrophoretic  migration  of IF  as  a  fl-globulin  in  serum.  75  ~l  of  C4-  and 
properdin-depleted human serum containing 0.01 M EDTA was subjected to electrophoresis 
in a 5 × 7.6-cm agarose slab at pH 8.6. After sectioning into 3-mm segments, the slices were 
eluted with 100 ~l VB. IF activity was determined by reconstitution of zymosan-dependent 
C3 consumption in IF-depleted serum utilizing 25/~l of the segment eluates, both untreated 
or heated to 56°C for 30 min. 
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FIG. 3.  IF exhibits an apparent mol wt of 70,000-120,000 daltons upon molecular sieve 
chromatography on Sephadex G-150. 10 ml of  C4 and properdin-depleted serum containing 
0.01  M  EDTA  applied to  a 5 × 100-cm Sephadex G-150  column equilibrated  with phosphate- 
buffer saline containing  2 mM  EDTA  at a flow rate of 50 ml/h. IF activity  of pools 
determined as in Fig.  2. 
cellulose at pH 7.4 and a NaC1 concentration gradient elution procedure. IF was 
eluted at 5.4 mmho/cm together with transferrin and C3b inactivator (Fig. 4). 
The active fractions (No. 60-68) were pooled, concentrated, and applied to a Bio- 
Gel A-0.5 M column equilibrated with phosphate-buffered saline, pH 7.3. The IF 
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FIo.  4.  DEAE chromatography ofpseudoglobulin  containing IF. 400 ml of  the pseudoglob- 
ulin fraction of normal human serum was applied to a 6 x  80-cm column of  DEAE cellulose 
equilibrated in 5 mM phosphate buffer, pH 7.3.  The column was washed until the break- 
through had eluted, after which a  NaC1 concentration gradient was started at tube no. 1. 
The protein was eluted together with transferrin and C3b inactivater. 
similar to that depicted in Fig. 3. The IF-containing material was then passed 
over an immune adsorbent column with specificity for IF and C3b inactivator. 
Elution  of unactivated  IF and  C3b inactivator  was accomplished  with  0.2  M 
glycine-HC1 buffer, pH 2.2.  The particular antiserum was chosen because it is 
the most potent anti-IF antiserum tested and because monospecific antiserum to 
IF is not yet available. 
Direct  demonstration  of IF  as  a  distinct  protein  was  possible by alkaline 
polyacrylamide gel etectrophoresis.  Fig. 5 shows the separation of IF from C3b 
inactivator and the identification of both proteins on the basis of their distinct 
activities. 
The sedimentation velocity of IF upon sucrose density gradient ultracentrifu- 
gation was found to be 7S (Fig. 6), which is similar to that of NF (18).,This value 
suggests a higher molecular weight than indicated by the results of the molecu- 
lar sieve chromatography experiments. By polyacrylamide gel electrophoresis in 
presence of SDS, the mol wt of IF was found to be slightly greater than that of 
IgG, approximately 170,000. After reduction of IF with dithiothreitol in 8 M urea 
and  1%  SDS  the  protein  exhibited  a  mol  wt  of 85,000  (Fig.  7).  This  result 
indicates that IF is composed of two probably identical polypeptide chains which 
are linked by disulfide bonds. IF therefore possesses a polypeptide chain struc- 
ture that is indistinguishable  from that of NF (19,  20). 
Whether a physiologically activated form of IF exists that is analogous to NF 
is not known. However, NF-like activity (12, 19-21) was generated by treatment 
of IF with 0.2 M glycine-HC1 buffer, pH 2.2, for 5 h at 4°C. Acid-treated IF (IF) 
led  to  C3  consumption  in  IF-  and  properdin-depleted  serum  in  absence  of 
zymosan,  stabilized  the  cell-bound  labile  C3  convertase,  C3b,B  and  caused 
agglutination  of EC3b only in presence of Factors B, D,  and Mg  (Table IV). 
Unlike unactivated IF, IF migrated as a 7-globulin upon agarose gel electropho- 
resis at pH 8.6 (Fig. 8). In this regard,  too, it resembles NF. 
Lysis of  Rabbit Erythrocytes Via the Alternative Pathway Requires IF but not 
Properdin.  Because properdin was found to be unessential  for initiation,  we R. D.  SCHREIBER,  O. GOTZE,  AND  H. J. MULLER-EBERHARD  1069 
FIG. 5.  Demonstration of IF as a distinct protein by polyacrylamide gel electrophoresis  of 
an immune adsorbent eluate containing IF, C3bINA, and immunoglobulin.  100 ~l of  IF was 
subjected to polyacrylamide gel electrophoresis  in 6% gels at pH 8.9. Gels were sliced into 2- 
mm segments and eluted with 200  ~1 VB.  IF activity determined as in Fig.  1.  C3bINA 
activity  was  determined  by the  destruction  of the  cell-bound  classical  C5  convertase 
(EAC4,°x~2,3) as described under Materials and Methods. 
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Fro. 6.  Sedimentation behavior of IF as a 7S component on sucrose density gradient 
ultracentrifugation.  150/~l  of  partially  purified  IF  was  subjected  to  ultracentrifugation  in  7- 
31% linear  sucrose density gradients for 16 h at 40,000  rpm. IF activity  determined by 
restoration  of  lysis  of  rabbit erythrocytes by IF-depleted serum. Markers: IgG, 6.6S;  Alb 
(human serum albumin), 4.5S;  and cyt  c (cytochrome c),  1.7S. 
explored  its  requirement  for  the  cytolytic  effect  of  the  properdin  pathway. 
Platts-Mills and Ishizaka (22) have shown that rabbit erythrocytes are unusual 
in that in human  serum they undergo lysis due to their ability to activate the 
alternative  pathway.  Using this  system, it was found that properdin-depleted 
serum  sustained  lysis  of the  cells,  although  to  a  lesser  extent  than  serum 
containing properdin. Lysis was virtually abolished after removal of the IF from 
the  serum  (Fig.  9).  The hemolytic  capacity of the  IF-depleted  serum  was  re- 
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FIG.  7.  Molecular weight (MW) determination of reduced IF by SDS polyacrylamide gel 
electrophoresis  in  7%  polyacrylamide  gels,  A  value  of 85,000  daltons  was  obtained  as 
compared  to  170,000  daltons for unreduced  IF as determined by the  same  method  (not 
shown). Markers: Phos a  (phosphorylase a), 100,000;  Fib a, fl, 7  (Fibrinogen a-, /3-, and -/- 
chains),  70,000,  60,000,  and 50,000,  respectively;  G6P Dehyd  (glucose-6-phosphate dehy- 
drogenase), 36,000; and chy (chymotrypsinogen), 25,000. 
TABLE  IV 
Functional Resemblance of Acid-Treated IF and NF 
Stabilized C3/C5 con- 
EC3b incubated with  vertase (Z)  Agglutination 
IF, B, D*  2.0  4+ 
NF,  B, D*  2.2  4+ 
IF, B, D*  0.0  0 
B, D*  0.2  0 
IF, wash, B, D$  0.1  0 
NF,  wash, B, D$  0.2  0 
Buffer*  0  0 
Z, 63% lysis. 
* Reaction mixtures containing 107 EC3b, 1 ~tg B, 13.5 ng D, with or without 20 ~l IF, 
NF, or IF and 10  -3 M Mg in a total vol of 70 ~l, incubated 10 min, 37°C, washed with 
GVBE, decayed 10 rain at 37°C,  and then mixed with 1 ml of C3-9 reagent. 
First incubation: 10  ~ EC3b, 20 ~l IF, or NF and 10  -3 M Mg for 10 min, 37°C,  washed 
with Mg GVB. Second incubation: 10 min, 37°C,  with 1 ~g B, 13.5 ng D, and 10  -~ M 
Mg in a total vol of 70 ~l. Cells were washed in GVBE, decayed 10 rain, 37°C,  then 
mixed with 1 ml C3-9 reagent. 
Discussion 
This is the first description of the IF of the properdin system. To our knowl- 
edge the  protein has  been heretofore unrecognized with  respect to  both  its 
function and its physicochemical  properties. IF is a 170,000 dalton pseudoglobu- 
lin with a sedimentation coefficient  of 7S and the electrophoretic  mobility of  a fl- 
globulin. It is composed of  two apparently identical polypeptide chains which are 
linked by disulfide bridges  and noncovalent forces. Its  biological activity is 
thermostable. The discrepancy encountered with molecular weight estimates 
using Sephadex filtration and SDS polyacrylamide gel electrophoresis suggest 
that IF is retarded on Sephadex filtration due to interaction with the polysac- 
charide. SCHREIBER,  Oo  GOTZE,  AND  H.  J.  MULLER-EBERHARD  S.  D° 
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FxG. 8.  Electrophoretic  behavior  of  IF  "activated"  by  treatment  at  low  pH.-l~  migrates  as 
a 7-globulin at pH 8.6.  75 ~I of  partially  purified  IF containing Ig as contaminant was 
subjected to electrophoresis  in a 5 ×  7.6-cm agarose slab.  After sectioning into  3-ram 
segments and elution  with VB, IF activity  was determined  by the ability  of  the eluates  to 
induce consumption of  C3 in  IF-depleted  serum in absence  of  zymosan. 
Serum  Depleted  of  C4 
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75-  Serum 
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FIG. 9.  Initiating  factor-dependent lysis  of  rabbit  erythrocytes  in presence or absence of 
properdin. Varying amounts of  C4, C4 and properdin, or C4 and IF-depleted  serum were 
incubated for 30 rain  at 37°C with 1.5 × 107 rabbit erythrocytes in a total  vol of 150 ~l. 
Reactions were stopped by dilution  with I ml cold  GVBE  and centrifugation. 
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FIG. i0.  Alternative pathway dependent  lysis  of  rabbit  erythrocytes  as a function  of  dose 
of  IF in IF-depleted serum. 1.5 × 107 rabbit  erythrocytes were incubated with 20 /~l IF- 
depleted serum and varying doses of  partially  purified  IF as described in Materials and 
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Some properties of IF resemble those of coagulation Factor XI (23). This factor 
is a relatively heat stable protein and has a tool wt of 160,000.  It is composed of 
two probably identical 80,000-dalton chains which are linked by disulfide bonds. 
Unlike IF, Factor XI is a zymogen which on activation is cleaved into 50,000 and 
33,000 dalton fragments. The enzyme and the zymogen have the electrophoretic 
mobility of 7-globulin. A relationship of IF to Factor XI is therefore considered 
unlikely. 
The function of IF is thought to be twofold: we assume that IF represents the 
recognition  unit  of the  alternative  pathway and we have presented  evidence 
that it generates the initial C3 convertase. That IF may indeed be the recogni- 
tion unit is suggested by the experiments utilizing IF-depleted serum. Although 
all known components of the properdin  system were present,  the system was 
unresponsive  to  all  genuine  alternative  pathway  activators  tested:  zymosan, 
inulin,  rabbit  erythrocytes,  and  antibody-coated  measles  virus-infected  cells 
(unpublished  observations).  The  recognition  unit  of the  alternative  pathway 
must be able to react with a  variety of disparate substances,  including fungal 
and bacterial cell wall constituents (24), certain animal cell membrane constitu- 
ents  (22,  25),  aggregates  of a  limited  number  of immunogiobulins  (26,  27), 
budding virus-infected cells coated with anti-virus antibody (28, 29), and chemi- 
cally defined substances such as benzyl-~-D-fructopyranoside (30),  polyglucose 
with consecutive a-l.3 and branched a-l.6 linkages (31), and dinitrophenylated 
albumin  (32).  It  will  be  the  task  of future  investigations  to  determine  the 
common chemical or physicochemical denominator of these substances in regard 
to their activator function. If IF is the recognition unit of the pathway, it would 
have to be able to recognize all of them. Certainly, purified IF is able to restore 
the function of IF-depleted serum with respect to any of the known activators of 
the pathway. The possibility cannot be excluded, however, that IF represents a 
group of closely related proteins which differ in recognition specificity. 
Its function as nucleus of the initial C3 convertase is obviously dependent on 
some kind of physical interaction with an activator substance. This postulated 
interaction  appears  to confer a  new property upon IF,  the  ability to bind to 
Factor B and to C3 and to generate a C3 convertase with Factor D and Mg. That 
IF is potentially capable of undergoing a conversion to an "activated" form was 
suggested by the activity expressed by acid-treated IF. That the "activated" form 
of IF exhibits an affinity primarily for activated Factor B  was documented by 
the dependence of agglutination of cells bearing C3b on the presence of activated 
Factor B. The entity to which "activated" IF attaches is the cell-bound complex 
C3b,B, not cell-bound C3b. 
By analogy  to  the  NF-dependent  C3  convertase  (12),  we propose  that  the 
physiologically activated IF utilizes not only Factors B and D, but also native C3 
to form the initial C3 convertase according to the following expression: 
Activator  IF +  C3  +  B  +  D  ,  C3,B,IF. 
Mg 
Whether Factor D is an integral subunit of the enzyme complex is not known. 
As demonstrated  in this  paper,  the biological function of this enzyme is to 
activate C3 and to deposit C3b on the surface of the activating particle, where it 
serves  as  a  subunit  and  anchor  of the  subsequently  formed  particle  bound R.  D.  SCHREIBER,  O.  GOTZE,  AND  H.  J.  MULLER-EBERHARD  1073 
enzymes, the  properdin activating principle,  and  finally as  the  receptor of 
activated properdin itself (3). 
The precise relationship of IF to NF is unknown. That antisera to NF react 
with IF is interpreted to indicate close immunological relatedness or identity of 
the two proteins. The first indication of the relationship of NF to a normal serum 
constituent which functions in  the properdin system was reported from our 
laboratory in 1974 (18). The virtual identity of IF and NF (19, 20) with respect to 
molecular weight and chain structure lends further support to their similarity. 
The two  proteins  differ,  however,  in  electrophoretic mobility and  apparent 
biological activity. Exploratory experiments with acid-treated IF show that an 
IF derivative may be produced in vitro that resembles NF in both biological 
activity and electrophoretic mobility. Like NF, acid-treated IF behaved like a ~- 
globulin upon electrophoresis, affixed itself  to EC3b,B,  stabilized this cell-bound 
enzyme, and caused agglutination of this cell-enzyme complex. A valid evalua- 
tion of NF will have to await a full understanding of IF. 
The difference in function of IF and properdin is fundamental. IF is operative 
in the earliest events of the properdin pathway, properdin is not. IF interacts 
primarily with activated Factor B, properdin interacts primarily with C3b. IF 
appears to be essential for the entire sequence as are Factors B, D, and C3 but 
properdin is not strictly an essential component as evidenced, for instance, by 
the  IF-dependent lysis  of rabbit  erythrocytes in  properdin-depleted serum. 
Other cellular systems seem to require properdin for detectable cytolysis. Mea- 
sles virus-infected cells coated with antibody to the virus are lysed by comple- 
ment via the alternative pathway. This reaction requires all components, in- 
cluding IF and properdin (unbpublished observations). Another example of the 
properdin-independent  function of the pathway is the cold-dependent activation 
of C3 in nephritic serum (33). This reaction proceeds entirely via the alternative 
pathway and requires Factors B and D, but not properdin. 
With the identification of IF as an essential, early acting component of the 
alternative pathway, it has been possible to delineate the physiological sequence 
of events of the  properdin pathway,  including the recruitment of precursor 
properdin and the functions of the recruited protein. Experiments pertaining to 
events aider the IF engagement will be reported separately (3 and footnote 1). 
Summary 
A novel component of the properdin system has been described which repre- 
sents a  heretofore unrecognized human serum protein. The protein has been 
tentatively termed the initiating factor (IF) because it functions in the initial 
reaction of the  properdin pathway.  IF  is  a  170,000 dalton  fl-pseudoglobulin 
which is composed of two presumably identical 85,000 dalton chains linked by 
disulfide bends. The protein reacts with antibody to nephritic factor, which is 
defined by  its  activity and  is  found in  the  serum of patients  with  certain 
nephritides. 
The activity of IF is heat stable. Upon treatment of serum with activators of 
the alternative pathway, the initial C3 convertase is assembled from IF, Factors 
B  and  D,  C3,  and magnesium without participation  of properdin.  It  is  the 
function of the enzyme to deposit C3b on the surface of the activator particles, 1074  ALTERNATIVE  PATHWAY  OF  COMPLEMENT 
thereby  affording  generation  of the  solid  phase  enzymes  of the  pathway,  a 
process that is a  prerequisite for properdin activation. 
By exposure to low pH, IF assumed the electrophoretic mobility of 7-globulin 
and acquired the ability to generate without activators a fluid phase C3 conver- 
tase  in serum.  Serum depleted  of IF did not allow activation of the properdin 
pathway. Serum depleted of properdin did permit activation of the pathway and 
expression  of  cytolytic  activity.  These  results  raise  the  possibility  that  IF 
represents the recognition unit of the pathway. 
We wish to thank Ms. Judith Powell, Ms. Lorraine Wood, and Ms. Mary Yelvington  for skillful 
technical  assistance. 
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